|
Pharma Marketletter
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Total result: 208 articles |
 Page 1 of 3 
|
Auxilium/Ipsen's Testim OKed in EU.(Brief Article)
December 20, 2004
Advexin improves breast cancer therapy.(Brief Article)
December 20, 2004
France: reimbursement cut on vasodilators.(Brief Article)
December 20, 2004
Pharma anti-counterfeiting conf.(Brief Article)
December 20, 2004
Nutra Pharma corrects November 9 statement.(Brief Article)
December 20, 2004
Prolysis and Proteom enter antibiotic collaboration.(Brief Article)
December 20, 2004
S-P's Peg-Intron launched in Japan.(Brief Article)
December 20, 2004
Future of parallel drug trade in enlarged Europe.
December 20, 2004
Galileo raises C$11.1M and changes name.(Brief Article)
December 20, 2004
Maxim's fiscal 2004 loss narrows.(Brief Article)
December 20, 2004
Chiron gets FDA warning letter.(Brief Article)
December 20, 2004
Connetics' Evoclin available in the USA.(Brief Article)
December 20, 2004
Bayer divests plasma business for $590M.(Brief Article)
December 20, 2004
Generics firm Hexal postpones listing.(Brief Article)
December 20, 2004
$57M placing by Genitope.(Brief Article)
December 20, 2004
$200M private placing by Bio-Rad.(Brief Article)
December 20, 2004
Pharmaxis raises further A$16.5M.(Brief Article)
December 20, 2004
Mylan/King merger: the saga continues.(Brief Article)
December 20, 2004
Demand surges for cell-based assays; F&S report.(Brief Article)
December 20, 2004
Pharmagene modifies alliance with Bayer Healthcare.
December 20, 2004
Further $7.8M financing for Introgen.(Brief Article)
December 20, 2004
LGC debuts new division at Genesis 2004.(Brief Article)
December 20, 2004
Phytopharm licenses Hoodia to Unilever.(Brief Article)
December 20, 2004
Neurocrine/GSK's CRF1 antagonist in Ph I.(Brief Article)
December 20, 2004
Abbott files Xinlay NDA with FDA.(Brief Article)
December 20, 2004
Benefits of long-term Zyprexa therapy.(Brief Article)
December 20, 2004
FDA rates Lannett's levothyroxine AB.(Brief Article)
December 20, 2004
Sepracor's Lunesta approved by FDA.(Brief Article)
December 20, 2004
FDA clears Amgen's Kepivance.(Brief Article)
December 20, 2004
SPECTRUM.(Illustration)
December 20, 2004
Pharma plant built in new record time of 14.5 months.(Brief Article)
December 20, 2004
DOV Pharma commences $65M offering.(Brief Article)
December 20, 2004
Cambridge Univ to coordinate CancerGRID.(Brief Article)
December 20, 2004
bioMerieux licenses App NeuroSolutions' tech for AD diagnosis.(Applied...
December 20, 2004
EWGAD highlights Protopic as superior in atopic dermatitis.(Brief Arti...
December 20, 2004
Invitrogen buys Bio Asia of China.(Brief Article)
December 20, 2004
European drug regulators revisit SSRIs, warn doctors on antidepressant...
December 20, 2004
Sirna's shares up on birth of dermatology unit.(Brief Article)
December 20, 2004
Germany: statutory health care reform a major election issue - by Gilb...
December 20, 2004
GSK acquires full rights for Bexxar from Corixa.(Brief Article)
December 20, 2004
Pfizer to sell 50% of French operations.(Brief Article)
December 20, 2004
UCB opens new $40M Keppra facility.(Brief Article)
December 20, 2004
GSK responds to CHMP opinion on use of Seroxat.(Brief Article)
December 20, 2004
Axis-Shield's preliminary results on target.(Brief Article)
December 20, 2004
US GAO backs Medicare switch away from AWP for physician-administered ...
December 20, 2004
US data exclusivity under Hatch-Waxman should be raised to 10 years, F...
December 20, 2004
GSK's Seretide Evohaler with built-in counter introduced.(GlaxoSmithKl...
December 20, 2004
German post-Vioxx warning on COX-2s.(COX-2 inhibitors)(Drug Commission...
December 20, 2004
Biomira incerases financing to $12.57M.(Brief Article)
December 20, 2004
Editor's views on pharma sector mergers.(Editorial)
December 20, 2004
Merck & Co slams Teva for response to petition.(Teva Pharmaceutical In...
December 20, 2004
Norgine announces external appointments and promotions.(Brief Article)
December 20, 2004
GTx gets exclusive US rights for Orion's toremifene.(Brief Article)
December 20, 2004
Stock Commentary - New York.
December 20, 2004
EPA administrator Michael Leavitt nominated as new US Health Secretary...
December 20, 2004
UK contributes to global smallpox vaccine stock.(Brief Article)
December 20, 2004
Pharmaceutical firms are conducting trials oversees.(Brief Article)
December 20, 2004
Wyeth looking for global approval of Tygacil.(Brief Article)
December 20, 2004
Additions to Italy's Prontuario.(Brief Article)
December 20, 2004
Biopure reduces net loss for 4th-qtr 2004.(Brief Article)
December 20, 2004
Shire's Equetro cleared by FDA for BD.(Shire Pharmaceuticals Group PLC...
December 20, 2004
Spanish doctors reject personal incentives.(Brief Article)
December 20, 2004
Conclusions of global summit on health res.(Research)
December 20, 2004
Teikoko Hormone and Greland to merge.(Teikoku Hormone Manufacturing Co...
December 20, 2004
CORRECTION: AstraZeneca's Cerovive.(Correction Notice)
December 20, 2004
Protherics sees profit for six-month period.(Brief Article)
December 20, 2004
GSK to start pivotal trial for Fluarix.(GlaxoSmithKline PLC)(Brief Art...
December 20, 2004
J&J's antibiotic offers hope against TB.(Johnson & Johnson, R207910, t...
December 20, 2004
Zydus eyes European outsourcing market.(Zydus Cadila)(Brief Article)
December 20, 2004
Inpharmatica raises L13.8M in financing round.(Brief Article)
December 20, 2004
Endo and Novartis will be key players in pain.(ENDO Pharmaceuticals In...
December 20, 2004
Positive new data for Bayer/GSK's Levitra.(Bayer Pharmaceuticals Corp....
December 20, 2004
Solvay files for new use of Aceon.(Solvay Pharmaceuticals Inc.)(Brief ...
December 20, 2004
Indian biotech regs.(National Biotech Regulatory Authority, regulation...
December 20, 2004
GSK suggests G8 as a platform for change.(GlaxoSmithKline PLC.)(Brief ...
December 20, 2004
|
1